Semler Scientific Inc (SMLR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Semler Scientific Inc stock (SMLR) is currently trading at $20.33. Semler Scientific Inc PE ratio is 5.04. Semler Scientific Inc PS ratio (Price-to-Sales) is 8.42. Analyst consensus price target for SMLR is $75.33. WallStSmart rates SMLR as Underperform.
- SMLR PE ratio analysis and historical PE chart
- SMLR PS ratio (Price-to-Sales) history and trend
- SMLR intrinsic value — DCF, Graham Number, EPV models
- SMLR stock price prediction 2025 2026 2027 2028 2029 2030
- SMLR fair value vs current price
- SMLR insider transactions and insider buying
- Is SMLR undervalued or overvalued?
- Semler Scientific Inc financial analysis — revenue, earnings, cash flow
- SMLR Piotroski F-Score and Altman Z-Score
- SMLR analyst price target and Smart Rating
Semler Scientific Inc
📊 No data available
Try selecting a different time range
SMLR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Semler Scientific Inc (SMLR)
SMLR trades at a significant discount to its Graham intrinsic value of $213.41, offering a 90% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Semler Scientific Inc (SMLR) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, eps growth, profit margin. Concerns around operating margin and price/sales. Fundamentals are solid but monitor weak areas for improvement.
Semler Scientific Inc (SMLR) Key Strengths (5)
Trading below book value, meaning the market prices it less than net assets
Earnings per share surging 357009.00% year-over-year
Keeps $86 of every $100 in revenue as net profit
75.61% of shares held by major funds and institutions
Solid profitability: $16 profit per $100 equity
Supporting Valuation Data
Semler Scientific Inc (SMLR) Areas to Watch (4)
Losing money on operations
Revenue declining -43.20%, a shrinking business
Very expensive at 8.4x annual revenue
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Semler Scientific Inc (SMLR) Detailed Analysis Report
Overall Assessment
This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 9 metrics analyzed, 5 register as strengths (avg 9.4/10) while 4 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, EPS Growth, Profit Margin. Valuation metrics including Price/Book (0.68) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 16.00%, Profit Margin at 86.20%. Growth metrics are encouraging with EPS Growth at 357009.00%.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, Price/Sales. Some valuation metrics including Price/Sales (8.42) suggest expensive pricing. Growth concerns include Revenue Growth at -43.20%, which may limit upside. Profitability pressure is visible in Operating Margin at -25.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 16.00% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -43.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Book, EPS Growth) and negatives (Operating Margin, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SMLR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SMLR's Price-to-Sales ratio of 5.47x trades at a deep discount to its historical average of 17.43x (12th percentile). The current valuation is 91% below its historical high of 58.83x set in Oct 2021, and 74% above its historical low of 3.14x in Dec 2016. Over the past 12 months, the PS ratio has compressed from ~9.9x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Semler Scientific Inc (SMLR) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Semler Scientific Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 43M with 43% decline year-over-year. Profit margins are strong at 86.2%, reflecting pricing power and operational efficiency.
Key Findings
Revenue contracted 43% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -33M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Semler Scientific Inc.
Bottom Line
Semler Scientific Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Semler Scientific Inc(SMLR)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that help healthcare providers evaluate and treat patients with chronic conditions in the United States. The company is headquartered in Santa Clara, California.